Xinxiang Tuoxin Pharmaceutical Co.,Ltd. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 422.92 million compared to CNY 388.43 million a year ago. Revenue was CNY 422.92 million compared to CNY 388.43 million a year ago.

Net income was CNY 109.48 million compared to CNY 65.89 million a year ago. Basic earnings per share from continuing operations was CNY 0.87 compared to CNY 0.7 a year ago. Diluted earnings per share from continuing operations was CNY 0.87 compared to CNY 0.7 a year ago.